![1]()
Opinion
Understanding messenger RNA and other SARS-CoV-2 vaccines
December 14, 2020
Technological advances make these new and revolutionary vaccines a reality.
![1]()
News
A multicenter trial of vena cava filters in severely injured patients
December 9, 2020
Can early (within 72 hours) prophylactic placement of inferior vena cava filter decrease the risk of pulmonary embolism or death in severely injured patients?
![1]()
News
COVID-19 and risk of clotting: ‘Be proactive about prevention’
December 8, 2020
"We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of thromboprophylaxis," authors of a review article say.
News
Excess antibiotics and adverse events in patients with pneumonia
December 8, 2020
Do longer courses of antibiotics given to patients hospitalized with pneumonia result in higher rates of adverse events?
![1]()
News
Assessing the impact of glucocorticoids on COVID-19 mortality
December 7, 2020
Glucocorticoids can benefit patients with significantly elevated C-reactive protein.
News
Obesity, hypoxia predict severity in children with COVID-19
December 4, 2020
Race, ethnicity, and socioeconomic status were not significant predictors of serious illness.
![1]()
News
CRP testing in acute COPD exacerbations cuts antibiotic use without compromising outcomes
December 2, 2020
Does C-reactive protein (CRP) point-of-care testing used in the assessment of acute chronic obstructive pulmonary disease (COPD) exacerbations in the primary care setting safely reduce antibiotic use?
News
CMS launches hospital-at-home program to free up hospital capacity
December 1, 2020
The agency will be giving more flexibility to ambulatory surgery centers (ASCs) to provide hospital-level care.
News
FDA expands Xofluza indication to include postexposure flu prophylaxis
November 25, 2020
“This expanded indication for Xofluza will provide an important option to help prevent influenza just in time for a flu season that is anticipated to be unlike any other.”
![1]()
News
Rationale for baricitinib’s use in COVID-19 patients demonstrated
November 24, 2020
“We went from modeling and mechanistic investigations to clinical tests in a number of settings and laboratory analysis in record time,” Dr. Justin Stebbing said.
